| Loss of LPAR6 and CAB39L dysregulates the basal-to-luminal urothelial differentiation program, contributing to bladder carcinogenesis. | Loss of LPAR6 and CAB39L dysregulates the basal-to-luminal urothelial differentiation program, contributing to bladder carcinogenesis.
Lee S, Bondaruk J, Wang Y, Chen H, Lee JG, Majewski T, Mullen RD, Cogdell D, Chen J, Wang Z, Yao H, Kus P, Jeong J, Lee I, Choi W, Navai N, Guo C, Dinney C, Baggerly K, Mendelsohn C, McConkey D, Behringer RR, Kimmel M, Wei P, Czerniak B., Free PMC Article | 06/14/2024 |
| Bioinformatics Prediction and Experimental Verification Identify CAB39L as a Diagnostic and Prognostic Biomarker of Kidney Renal Clear Cell Carcinoma. | Bioinformatics Prediction and Experimental Verification Identify CAB39L as a Diagnostic and Prognostic Biomarker of Kidney Renal Clear Cell Carcinoma.
Wu Y, Xu Z, Chen X, Fu G, Tian J, Shi Y, Sun J, Jin B., Free PMC Article | 05/3/2023 |
| Identification of HLA-A*0201-restricted CTL Epitopes for MLAA-34-specific Immunotherapy for Acute Monocytic Leukemia. | Identification of HLA-A*0201-restricted CTL Epitopes for MLAA-34-specific Immunotherapy for Acute Monocytic Leukemia.
Bai J, Wang J, Yang Y, Wang F, He A, Zhang W. | 01/22/2022 |
| Targeted silencing of genes related to acute monocytic leukaemia by CpG(B)-MLAA-34 siRNA conjugates. | Targeted silencing of genes related to acute monocytic leukaemia by CpG(B)-MLAA-34 siRNA conjugates.
Huang B, He A, Zhang P, Ma X, Yang Y, Wang J, Wang J, Zhang W. | 08/21/2021 |
| minimal active region of MLAA-34 located between 402 bp and 200 bp | [Cloning of New Antigen Gene MLAA-34 Promoter and Identification of Core Region in Acute Monocytic Leukemia].
Lei B, Zhang WG, He AL, Chen YX, Cao XM, Zhao WH, Wang JL, Liu J, Ma XR, Zhang PY, Bai J. | 07/13/2019 |
| Our data demonstrate that CAB39L is a novel tumor suppressor in gastric cancer | CAB39L elicited an anti-Warburg effect via a LKB1-AMPK-PGC1α axis to inhibit gastric tumorigenesis.
Li W, Wong CC, Zhang X, Kang W, Nakatsu G, Zhao Q, Chen H, Go MYY, Chiu PWY, Wang X, Ji J, Li X, Cai Z, Ng EKW, Yu J., Free PMC Article | 03/2/2019 |
| Frameshift Mutations of CAB39L are associated with Gastric and Colorectal Cancers. | Frameshift Mutations of CAB39L, an Activator of LKB1 Tumor Suppressor, in Gastric and Colorectal Cancers.
Choi MR, An CH, Yoo NJ, Lee SH. | 10/22/2016 |
| In conclusion, our current results provide new evidence that MLAA-34 may be a novel anti-apoptotic factor in vitro, and the data presented here show a strong correlation between anti-apoptosis with the upregulation of MLAA-34. | The expression and functional characterization associated with cell apoptosis and proteomic analysis of the novel gene MLAA-34 in U937 cells.
Zhang WJ, Zhang WG, Zhang PY, Cao XM, He AL, Chen YX, Gu LF. | 06/15/2013 |
| our data indicate that MLAA-34 may be used as a prognostic marker for treatment decision-making in acute monocytic leukemia | Quantitative assessment of MLAA-34 expression in diagnosis and prognosis of acute monocytic leukemia.
Zhao J, He A, Zhang W, Meng X, Gu L., Free PMC Article | 05/21/2011 |
| Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator) | Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.
Rose JE, Behm FM, Drgon T, Johnson C, Uhl GR., Free PMC Article | 06/30/2010 |
| It was proposed that a splice variant MLAA-34 of CAB39L associated with acute monocytic leukemia. MLAA-34 was identified and characterized. Identification and functional characterization of the novel acute monocytic leukemia associated antigen MLAA-34 | Identification and functional characterization of the novel acute monocytic leukemia associated antigen MLAA-34.
Zhang PY, Zhang WG, He AL, Wang JL, Li WB., Free PMC Article | 01/21/2010 |